Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting

Journal of the Medical Association of Thailand

Volumn 82, Issue 9, 1999, Pages 914-920

  Chiersilpa, Arkom ^a   Ngow, Jeerapa ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Cisplatin Induced Nausea and Vomiting; Efficacy; Prevention; Tolerability; Tropisetron

Indexed keywords

CISPLATIN; DEXAMETHASONE; TROPISETRON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; STUPOR; TUMOR LOCALIZATION; VOMITING;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; NAUSEA; VOMITING;

EID: 0042415463     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. 3 receptor antagonist properties of ICS 205-930, GR 38032F and zaclopride. J Pharmacol Exp Ther 1989; 248: 197-201.
2. Anderson H, Howell A, Sage T, et al. Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting, Sandoz study code: ICS 3508, data on file, 1990.
3. Dogliotti L, Antonacci RA, Paze E, et al. Three years experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. Drugs 1992; 43 (Suppl 3): 6-10.
4. Leibundgut U, Lancranjan I. First results with ICS 205-930 in prevention of chemotherapy-induced emesis. The Lancet 1987; May 23: 1198.
5. Bruntsch U, Rufenacht E, Parker I, et al. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy. Ann Oncology 1993; 4 (suppl 3): 25-9.
6. Sorbe B. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. Ann Oncology 1993; 4 (suppl 3): 39-42.